Evidence map›Paper›PMID 35347146›Full record

ArticleScientific reports2022

Author Correction: Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer.

Rogier Aäron Gaiser, Alberto Pessia, Zeeshan Ateeb, Haleh Davanian, Carlos Fernández Moro, Hassan Alkharaan, Katie Healy, Sam Ghazi, Urban Arnelo, Roberto Valente and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Rogier Aäron GaiserDivision of Clinical Diagnostics and Surgery, DENTMED, Karolinska Institutet, Huddinge, Sweden.
Alberto PessiaMetabolomics Unit, Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0001-8607-9191
Zeeshan AteebDivision of Surgery, CLINTEC, Karolinska University Hospital, Stockholm, Sweden.
Haleh DavanianDivision of Clinical Diagnostics and Surgery, DENTMED, Karolinska Institutet, Huddinge, Sweden.
Carlos Fernández MoroDivision of Pathology, Department of Clinical Pathology/Cytology, Karolinska University Hospital, Huddinge, Sweden.ORCID http://orcid.org/0000-0001-6863-5959
Hassan AlkharaanDivision of Clinical Diagnostics and Surgery, DENTMED, Karolinska Institutet, Huddinge, Sweden.
Katie HealyDivision of Clinical Diagnostics and Surgery, DENTMED, Karolinska Institutet, Huddinge, Sweden.
Sam GhaziDivision of Pathology, Department of Clinical Pathology/Cytology, Karolinska University Hospital, Huddinge, Sweden.
Urban ArneloDivision of Surgery, CLINTEC, Karolinska University Hospital, Stockholm, Sweden.
Roberto ValenteDivision of Surgery, CLINTEC, Karolinska University Hospital, Stockholm, Sweden.
Vidya VelagapudiMetabolomics Unit, Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Margaret Sällberg ChenDivision of Clinical Diagnostics and Surgery, DENTMED, Karolinska Institutet, Huddinge, Sweden. margaret.chen@ki.se.
Marco Del ChiaroDivision of Surgery, CLINTEC, Karolinska University Hospital, Stockholm, Sweden. marco.delchiaro@ucdenver.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35347146
PMCPMC8960862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.